Cancer: Drugs

Department of Health written question – answered on 29th January 2015.

Alert me about debates like this

Photo of Geoffrey Clifton-Brown Geoffrey Clifton-Brown Chair, Committee of Selection

To ask the Secretary of State for Health, what information his Department holds on studies which have been carried out on the efficacy of the drug pemetrexed; if his Department will again make that drug available on the NHS; and if he will make a statement.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. It has published guidance on Pemetrexed for types of lung cancer, and recommends its use to some patients based on certain clinical criteria.

There is a legal requirement on the National Health Service to provide funding for treatments and drugs recommended by NICE technology appraisal guidance within three months of the NICE technology appraisal guidance being published.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.